Skip to main content

Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Introduction

  • Chapter
  • 812 Accesses

Abstract

More than six decades have elapsed since the introduction of corticosteroids into the pharmacologic armamentarium of pediatricians. Despite the widespread clinical use of these agents for many years, several questions remain concerning their appropriate therapeutic role, indications, possible regimens, and adverse effects. The discovery of corticosteroids can be considered one of the most important therapeutic revolutions of the last century. Steroids became crucial for the treatment of several inflammatory and rheumatic diseases, including diseases that occur during childhood. However, the great enthusiasm over the discovery of corticosteroids was hampered in later years by the identification of important side effects that raised concerns regarding steroid therapy. Thus, in the past years, research focused on the development of new steroid compounds with lower toxicity and higher efficacy as well as on novel therapeutic regimens. Now, 60 years later, treatment with corticosteroids has stood the test of time, and despite the well-known side effects they are still a keystone in the therapy of many disorders and can sometimes be life-saving.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lundberg IE, Grundtman C, Larsson E, Klareskog L (2004) Corticosteroids–from an idea to clinical use. Best Pract Res Clin Rheumatol 18:7–19

    Article  CAS  PubMed  Google Scholar 

  2. Benedek TG (2011) History of the development of corticosteroid therapy. Clin Exp Rheumatol 29(5 Suppl):S-5–S-12

    Google Scholar 

  3. Chast F (2013) History of corticotherapy. Rev Med Interne 34:258–263

    Article  CAS  PubMed  Google Scholar 

  4. Raju TN (1999) The Nobel chronicles. 1950: Edward Calvin Kendall (1886–1972); Philip Showalter Hench (1896–1965); and Tadeus Reichstein (1897–1996). Lancet 353:1370

    Article  CAS  PubMed  Google Scholar 

  5. Wolman B (1951) The use of oral cortisone in paediatrics. Br Med J 2:1246–1250

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. McCall MF, Ross A, Wolman B, Burns AD, Harpur EM, Goldbloom A (1952) The nephrotic syndrome in children treated with ACTH and cortisone. Arch Dis Child 27:309–321

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24:181–197

    CAS  PubMed  Google Scholar 

  8. Spirer Z, Hauser GJ (1985) Corticosteroid therapy in pediatric practice. Adv Pediatr 32:549–587

    CAS  PubMed  Google Scholar 

  9. Hollander JL, Brown EM, Jessar RA, Brown CY (1951) Comparative effects of use of hydrocortisone as a local anti-arthritic agent. JAMA 147:1629–1635

    Article  CAS  Google Scholar 

  10. Pekarek B, Osher L, Buck S, Bowen M (2011) Intra-articular corticosteroid injections: a critical literature review with up-to-date findings. Foot (Edinb) 21:66–70

    Article  Google Scholar 

  11. Buehring B, Viswanathan R, Binkley N, Busse W (2013) Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol 132:1019–1030

    Article  CAS  PubMed  Google Scholar 

  12. Wolthers OD, Pedersen S (1990) Short term linear growth in asthmatic children during treatment with prednisolone. BMJ 301:145–148

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Allen DB, Mullen M, Mullen B (1994) A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 93:967–976

    Article  CAS  PubMed  Google Scholar 

  14. Pope E, Krafchik BR, Macarthur C, Stempak D, Stephens D, Weinstein M, Ho N, Baruchel S (2007) Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 119:e1239–e1247

    Google Scholar 

  15. Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD (2000) Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106:651–659

    Article  CAS  PubMed  Google Scholar 

  16. Walton J, Ney RL (1975) Current concepts of corticosteroids – uses and abuses. Dis Mon Jun:3–35

    Google Scholar 

  17. Brouwer MC, McIntyre P, Prasad K, van de Beek D (2013) Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 6:CD004405

    Google Scholar 

  18. Zalmanovici Trestioreanu A, Yaphe J (2013) Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev 12:CD005149

    Google Scholar 

  19. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, Johnson DW, Klassen TP, Hartling L (2013) Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 6:CD004878

    Google Scholar 

  20. Kramer S, Rottier BL, Scholten RJ, Boluyt N (2013) Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2:CD010352

    Google Scholar 

  21. Cates CJ, Karner C (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev 4:CD007313

    Google Scholar 

  22. Kew KM, Karner C, Mindus SM, Ferrara G (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 12:CD009019

    Google Scholar 

  23. Chauhan BF, Chartrand C, Ducharme FM (2013) Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2:CD009611

    Google Scholar 

  24. Goyal V, Chang AB (2014) Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. Cochrane Database Syst Rev 6:CD010327

    Google Scholar 

  25. Doyle LW, Ehrenkranz RA, Halliday HL (2014) Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001146

    Google Scholar 

  26. Doyle LW, Ehrenkranz RA, Halliday HL (2014) Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001145

    Google Scholar 

  27. Anderson-James S, Marchant JM, Acworth JP, Turner C, Chang AB (2013) Inhaled corticosteroids for subacute cough in children. Cochrane Database Syst Rev 2:CD008888

    Google Scholar 

  28. Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, Kaplan GG, Benchimol EI (2014) Budesonide for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 8:CD002913

    Google Scholar 

  29. Cheng K, Ashby D, Smyth RL (2013) Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev 6:CD000407

    Google Scholar 

  30. Beer H, Southern KW, Swift AC (2013) Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis. Cochrane Database Syst Rev 4:CD008253

    Google Scholar 

  31. Syed MI, Suller S, Browning GG, Akeroyd MA (2013) Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children. Cochrane Database Syst Rev 4:CD008512

    Google Scholar 

  32. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA (2013) Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 8:CD006764

    Google Scholar 

  33. Crowther CA, Alfirevic Z, Han S, Haslam RR (2013) Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 11:CD000019

    Google Scholar 

  34. Chen HS, Wang W, Wu SN, Liu JP (2013) Corticosteroids for viral myocarditis. Cochrane Database Syst Rev 10:CD004471

    Google Scholar 

  35. Stoll ML, Cron RQ (2014) Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J 12:13

    Article  PubMed Central  PubMed  Google Scholar 

  36. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482

    Article  Google Scholar 

  37. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA (2014) Management of Kawasaki disease. Arch Dis Child 99:74–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Vigo G, Zulian F (2012) Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev 12:52–55

    Article  PubMed  Google Scholar 

  39. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551

    Article  CAS  PubMed  Google Scholar 

  40. Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH (2014) Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275:104–115

    Article  CAS  PubMed  Google Scholar 

  41. Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW (2007) EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 66:1560–1567

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW (2010) Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis 69:1913–1919

    Article  PubMed  Google Scholar 

  43. Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 72:1905–1913

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Saggese MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Saggese, G., Vierucci, F. (2015). Systemic Corticosteroids for Autoimmune/Inflammatory Disorders in Children: Introduction. In: Cimaz, R. (eds) Systemic Corticosteroids for Inflammatory Disorders in Pediatrics. Adis, Cham. https://doi.org/10.1007/978-3-319-16056-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16056-6_1

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-16055-9

  • Online ISBN: 978-3-319-16056-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics